AAV Total Capsid Quantification Kits | AAVX & AAV9
The AAVX and AAV9 Total Capsid Quantification Kits extend the Amperia™ Protein Quantification System for streamlined measurement of adeno-associated virus (AAV) vectors. Incorporating CaptureSelect™ affinity reagents from Thermo Fisher Scientific, the kits provide robust, reproducible assays for both broad serotype coverage and AAV9-specific quantification.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Designed for scientists working across gene therapy research and development, the AAVX and AAV9 kits simplify total capsid measurement by reducing the need for in-house assay optimisation. Each kit is supplied in a ready-to-use format with sensor strips, reagents, and pre-set assay templates for seamless integration with the Amperia™ system. The assays use a sandwich-style immunoassay with electrochemical detection, enabling accurate quantification from both purified and complex samples.
Key Features
- Ready-to-use format tailored for the Amperia™ system
- Incorporates CaptureSelect™ affinity reagents for specificity and consistency
- Sandwich immunoassay with electrochemical detection — no optics or fluidics required
- Supports both purified preparations and in-process samples
- Pre-set templates for straightforward assay setup
Applications
- Total capsid quantification in AAV research and development
- Process development and optimization in gene therapy workflows
- Monitoring titres across upstream and downstream steps
- Comparative studies across serotypes or process conditions
Empowering AAV quantification for gene therapy research
Adeno-associated virus (AAV) vectors have become a cornerstone of gene therapy, valued for their safety, broad targeting capabilities, and adaptability across therapeutic applications.
In this application note, Abselion demonstrates the Amperia™ platform, offering a streamlined alternative – using a sandwich-format assay with high-affinity antibodies from Thermo Fisher Scientific to quantify multiple AAV serotypes with robust performance across sample types.
TechTalk: Fast, accurate, accessible quantification across diverse biologics
Friday, January 23 at 16:00 GMT | 17:00 CET | 11:00 EST | 08:00 PST
Quantifying antibodies, AAV capsids, and tagged proteins directly from crude or partially clarified samples remains a common bottleneck in many biologics workflows.
In this 20-minute SelectScience TechTalk, Dr. Paolo Romele, VP of Science, Abselion will introduce the electrochemical approach used in the Amperia™ benchtop platform, which combines affinity-based capture with Redox Electrochemical Detection (RED) to provide quantitative measurements without relying on optical readouts.
Join this educational and technology-focused session to learn practical examples illustrating how these assays operate across biologics applications.
Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.
TechTalk details
- Cost: Free to attend
- Location: Online
- Duration: 20 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
